A multi-center randomized control trial of JUC Long-acting Antimicrobial Material in preventing infection after percutaneous nephrostomy

A multi-center randomized control trial of JUC Long-acting Antimicrobial Material in preventing infe

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005278

Enrollment

Unknown

Registered

2014-01-14

Start date

2014-11-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Percutaneous nephrostomy

Interventions

Two groups:JUC+routine care vs routine care

Eligibility

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18-65 years old; patients requiring percutaneous nephrolithotomy for various causes; patients who agreed to participate and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with symptoms of unrinary tract infection, hematuria and dysuria at enrollment; 2. Patients with diabetes mellitus; 3. Pregnant and lactating women; 4. Patients receiving antibiotics 72 hours before enrollment; 5. Patients allergic to latex, hydrogels (silicone) and ammonium salt; 6. Patients with mental disorders; 7. Patients with other immunosuppressive diseases.

Design outcomes

Primary

Measure	Time frame
Bacteriuria;exit-site infection;	—

Countries

China

Contacts

Public ContactYe Zhangqun

zhangqun_ye@yahoo.com.cn+86 13507191761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026